PATENT CLAIM ANALYSIS

Application Number: 15957806
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["530", "326000"]

Abstract:
Methods and compositions related to the selective, specific disruption of multiple ligand-receptor signaling interactions, such as ligand-receptor interactions implicated in disease, are disclosed. These interactions may involve multiple cytokines in a single receptor family or multiple ligand receptor interactions from at least two distinct ligand-receptor families. The compositions may comprise polypeptides having composite sequences that comprise sequence fragments of two or more ligand binding sites. The methods and compositions may involve sequence fragments of two or more ligand binding sites that are arranged to conserve the secondary structure of each of the ligands from which the sequence fragments were taken.

Claim (Index 10):
The therapeutic composite peptide conjugate of  claim 1 , wherein the therapeutic composite peptide conjugate is used for a cosmetic purpose.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.7541
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15287517', '13980305', '14852240', '15179900', '15474312']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8120554957533548
- 35 USC 102 Novelty (BERT): 0.5835281340241418
- Combined Prediction Score: 0.7892027595804335
- Mean Citation Score: 581.95412
- Max Citation Score: 593.53973
- Similarity Product: 396.97723502404153

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test